Anika Nagelkerke
Overview
Explore the profile of Anika Nagelkerke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
4038
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jansen E, van der Koog L, Elferink R, Rafie K, Nagelkerke A, Gosens R, et al.
Small
. 2025 Feb;
:e2411096.
PMID: 39945036
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, with a significant impact on low- and middle-income countries, making it a critical challenge for global health...
2.
3.
Gladysz M, Ubels D, Koch M, Amirsadeghi A, Alleblas F, van Vliet S, et al.
Adv Healthc Mater
. 2024 Nov;
14(6):e2401504.
PMID: 39533454
Melt electrowriting (MEW) enables precise scaffold fabrication for biomedical applications. With a limited number of processable materials with short and tunable degradation times, polyhydroxyalkanoates (PHAs) present an interesting option. Here,...
4.
van der Koog L, Boerrigter M, Gorter I, Gosens R, Nagelkerke A
Eur J Pharmacol
. 2024 Apr;
974:176612.
PMID: 38677537
One of the main pathological features of chronic obstructive pulmonary disease (COPD) is the loss of functional alveolar tissue as a consequence of impaired regenerative capacities (emphysema). Recent research suggests...
5.
Li M, Larsen F, van den Heuvel M, Gier K, Gorter A, Oosterhuis D, et al.
Nutrients
. 2024 Mar;
16(5).
PMID: 38474754
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing healthcare problem with limited therapeutic options. Progress in this field depends on the availability of reliable preclinical models. Human precision-cut liver...
6.
Dorado E, Doria M, Nagelkerke A, McKenzie J, Maneta-Stavrakaki S, Whittaker T, et al.
J Extracell Vesicles
. 2024 Mar;
13(3):e12419.
PMID: 38443328
Extracellular vesicles (EVs), including exosomes and microvesicles, mediate intercellular communication in cancer, from development to metastasis. EV-based liquid biopsy is a promising strategy for cancer diagnosis as EVs can be...
7.
Ahmed M, Jurczak K, Lynn Jr N, Mulder J, Verpoorte E, Nagelkerke A
Sci Rep
. 2024 Feb;
14(1):2831.
PMID: 38310102
The application of microfluidic devices as next-generation cell and tissue culture systems has increased impressively in the last decades. With that, a plethora of materials as well as fabrication methods...
8.
Migulina N, de Hilster R, Bartel S, Vedder R, van den Berge M, Nagelkerke A, et al.
Am J Physiol Cell Physiol
. 2023 Nov;
326(1):C177-C193.
PMID: 37955339
Fibroblasts are the main producers of extracellular matrix (ECM) responsible for ECM maintenance and repair, a process often disrupted in chronic lung diseases. The accompanying mechanical changes adversely affect resident...
9.
Elzinga F, Khalili B, Touw D, Prins J, Olinga P, Leuvenink H, et al.
J Clin Med
. 2023 Jul;
12(13).
PMID: 37445348
Quantification of fetal drug exposure remains challenging since sampling from the placenta or fetus during pregnancy is too invasive. Currently existing in vivo (e.g., cord blood sampling) and ex vivo...
10.
Gandek T, van der Koog L, Nagelkerke A
Adv Healthc Mater
. 2023 Jun;
12(25):e2300319.
PMID: 37384827
A key aspect for successful drug delivery via lipid-based nanoparticles is their internalization in target cells. Two prominent examples of such drug delivery systems are artificial phospholipid-based carriers, such as...